Financial Data and Key Metrics Changes - The company reported GAAP diluted EPS of $1.25 and non-GAAP diluted EPS of $1.22 for Q1 2025, compared to $1.06 in Q1 2024, reflecting a significant increase in earnings driven by rate recovery and colder weather [6][9][10] - The company affirmed its long-term rate base and earnings per share growth rate targets of 4% to 6% [6][19] Business Line Data and Key Metrics Changes - The Electric and Gas segments contributed strongly to the earnings, with margin improvements driven by new rates and favorable weather conditions [9][10] - New rates contributed $0.20 to margin improvement, while favorable loads added $0.13, resulting in a total margin increase [10][11] Market Data and Key Metrics Changes - The Montana rate review is nearing completion, with a full natural gas settlement and a partial electric settlement reached [7][14] - The average bill impact from the gas case is approximately 9%, maintaining rates below the national average [18] Company Strategy and Development Direction - The company is focusing on opportunities with data centers and new large load opportunities, potentially achieving greater than 6% EPS growth [8] - The company is committed to maintaining a 5% dividend yield and a total growth profile of 9% to 11% over the next five years [8][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in delivering on earnings and rate-based growth commitments over the long term, despite not providing specific 2025 earnings guidance until the conclusion of the Montana rate review [19][20] - The company expects a lower contribution to overall earnings in Q2 2025 due to the timing of rate implementations [20] Other Important Information - The Montana legislature has passed wildfire and other constructive bills, which are pending the governor's approval, providing significant legal protections for the company [22][24] - The company has successfully priced $500 million of long-term debt to address its financing needs for 2025 [13][14] Q&A Session Summary Question: On the tariff proceeding and data centers - The company is in discussions with multiple parties regarding data centers and expects to finalize contracts with two parties, Atlas and Sabey, by the end of Q2 2025 [40][43][44] Question: EPS guidance for 2025 - Management expects to stay within the 4% to 6% EPS range long-term but acknowledges variability in achieving this target [50] Question: Changes in electric average customer counts - The change in customer counts was due to a new system for counting street lighting districts, with overall customer growth remaining around 1.5% [54][55] Question: Long-term capacity planning - The company is considering natural gas or nuclear as potential replacements for Colstrip, depending on regulatory timelines [64][66] Question: SB301 and approval processes - The 90-day cost prudency review is deemed appropriate, with no overlapping of approval processes expected [68]

Core Insights - Thermo Fisher Scientific Inc. reported first-quarter 2025 adjusted earnings per share (EPS) of $5.15, exceeding the Zacks Consensus Estimate by 1% and reflecting a year-over-year increase of 0.8% [1] - The company's GAAP EPS was $3.98, marking a 15% increase year over year [1] - Following the earnings announcement, shares of Thermo Fisher rose 1.7% in pre-market trading [2] Revenue Performance - Total revenues for the quarter reached $10.36 billion, a 0.2% increase year over year, surpassing the Zacks Consensus Estimate by 1.1% [3] - Organic revenues increased by 1% year over year [3] Segment Analysis - Life Sciences Solutions segment (22.6% of total revenues) saw revenues increase by 2.4% year over year to $2.34 billion, exceeding estimates [4] - Analytical Instruments segment (16.6%) reported a 1.8% year-over-year increase in revenues to $1.72 billion, which fell short of estimates [5] - Specialty Diagnostics segment (11.1%) experienced a 3.5% year-over-year revenue increase to $1.15 billion, surpassing predictions [6] - Laboratory Products and Biopharma Services segment (54.4%) saw a decline of 1.4% year over year, with revenues at $5.64 billion, slightly below estimates [7] Margin Performance - Gross margin for the first quarter was 41.6%, contracting by 5 basis points year over year due to a 0.3% rise in the cost of revenues [8] - Selling, general and administrative expenses decreased by 0.6% to $1.72 billion, while research and development expenses increased by 3.3% to $342 million [8] - Adjusted operating margin was 21.7%, reflecting a contraction of 2 basis points [8] Financial Position - At the end of Q1 2025, cash and cash equivalents and short-term investments totaled $5.95 billion, up from $5.57 billion at the end of Q4 2024 [9] - Net cash from operating activities was $723 million, down from $1.25 billion a year ago [10] - The company has a consistent dividend-paying history, with a five-year annualized dividend growth of 15.10% [10] Strategic Developments - During the first quarter, Thermo Fisher launched several innovative products, including the Thermo Scientific Vulcan Automated Lab and Olink Reveal proteomics kits, contributing to commercial success [12] - The company announced an agreement to acquire Solventum's Purification & Filtration Business for $4.1 billion in cash [12] Overall Assessment - Thermo Fisher's first-quarter results exceeded expectations in terms of earnings and revenues, with growth in most segments except for Laboratory Products and Biopharma Services [11] - The contraction in margins was noted as a concern, and the company is expected to provide guidance for 2025 in an upcoming earnings call [11]

Core Viewpoint - Boeing has secured a significant contract from the Department of Defense, leading to a 3.1% increase in its stock, while Lockheed Martin's stock fell by 5.8% due to losing the contract [1] Boeing - Boeing has faced numerous challenges over the past five years, including the suspension of its dividend in March 2020 due to the COVID-19 pandemic and issues with the Boeing 737 Max, including a recent investigation revealing quality control problems [3][5] - The company anticipates a ramp-up in new aircraft versions and expects to reduce losses in its Defense, Space & Security segment, guiding for positive free cash flow (FCF) in the second half of 2025 [4] - Boeing's backlog has grown significantly, reaching $521 billion at the end of 2024, with 5,500 commercial airplanes ordered, indicating strong demand despite execution challenges [5] - Analysts project further losses in 2025, but expect a turnaround with earnings per share (EPS) of $4.23 starting in 2026, making the stock potentially attractive if the company can manage its backlog effectively [6] Lockheed Martin - Lockheed Martin is characterized by its profitability and a consistent dividend increase for 22 consecutive years, with a valuation of less than 20 times trailing earnings and free cash flow [7] - The company has experienced weak growth recently, highlighted by a disappointing quarter and guidance, leading to a 9.5% decline in stock year-to-date [8][9] - Lockheed's adjusted EPS guidance for 2024 is between $27 and $27.30, with a projected EPS of $29.75 in 2026, indicating modest growth of 6.3% compared to 2024 [9] - Unlike Boeing, Lockheed has a strong track record of managing its backlog and delivering profitable programs, such as the F-35 fighter jet [10] Investment Considerations - The choice between Boeing and Lockheed Martin depends on investment objectives and risk tolerance; Boeing presents higher risk with potential for greater rewards, while Lockheed offers stability and consistent dividends [11][12] - Boeing's balance sheet is weaker than Lockheed's, with a financial debt-to-equity ratio of 0.4 and a debt-to-capital ratio over 100%, suggesting a need for financial improvement before reinstating dividends [13]

Core Viewpoint - The market anticipates Aptiv PLC (APTV) will report a year-over-year increase in earnings driven by higher revenues when it releases its results for the quarter ended June 2024, with a consensus EPS estimate of $1.37, reflecting a +9.6% change from the previous year [1][2] Group 1: Earnings Expectations - The expected revenue for Aptiv is $5.34 billion, which represents a 2.8% increase from the same quarter last year [2] - The consensus EPS estimate has been revised down by 0.74% over the last 30 days, indicating a reassessment by analysts [2] Group 2: Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that Aptiv has a negative Earnings ESP of -1.18%, suggesting analysts have become bearish on the company's earnings prospects [5] - The stock currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [5][6] Group 3: Historical Performance - In the last reported quarter, Aptiv exceeded the expected earnings of $1.05 per share by delivering $1.16, resulting in a surprise of +10.48% [7] - Over the past four quarters, Aptiv has consistently beaten consensus EPS estimates [7] Group 4: Market Sentiment - An earnings beat or miss is not the sole determinant of stock price movement, as other factors can influence investor sentiment [8] - Despite the current outlook, Aptiv does not appear to be a compelling candidate for an earnings beat, and investors should consider additional factors before making decisions [8]